The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...
It was during the 70s when Bayer’s pharmaceuticals’ sales began to ... its own name and using its own Bayer Cross corporate logo. This was under the leadership of Dr Manfred Schneider, who ...
“I am thrilled to join such an innovative company at the forefront of gene editing,” said Briggs Morrison, M.D. “I look forward to collaborating with the Board and the management team to drive CRISPR ...
GERMANTOWN, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable ...
The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering. The report provides insights into Bayer AG's tech activities, including its digital ...
Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...
A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals ...
Bayer expects its pharmaceutical business to return to growth in 2027 as the launch new therapies is expected to offset ...
2025--(BUSINESS WIRE)--On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback